Searchlight Pharma Inc. to Acquire Miravo Healthcare (Nuvo Pharmaceuticals d/b/a Miravo Healthcare)
February 7, 2023
Miravo Healthcare (Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare) announced it has filed and is mailing special meeting materials for a shareholder vote on a proposed plan of arrangement with Searchlight Pharma Inc. Under the arrangement, Searchlight Pharma will acquire all issued and outstanding common shares of Miravo for cash consideration of $1.35 per share.
- Buyers
- Searchlight Pharma Inc.
- Targets
- Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Apotex Acquires Searchlight Pharma
April 2, 2024
Pharmaceuticals
Apotex Inc. has completed the acquisition of Montreal-based Searchlight Pharma Inc., integrating Searchlight as Apotex's Specialty Pharma Division to expand its branded and specialty pharmaceutical capabilities. The deal adds Searchlight's portfolio of more than 60 products across women's health, dermatology, allergy, pain management and hospital specialty markets, and strengthens Apotex's commercial footprint in Quebec and across the Americas.
-
Citrus Health Group and NaviMed Capital Acquire Mirador Global, LLC
September 9, 2024
Healthcare Services
Citrus Health Group, together with investor NaviMed Capital, acquired Mirador Global, LLC, a Kennett Square–based commercialization and market access consulting firm. The deal brings Mirador’s launch planning, market access, and commercial strategy expertise into Citrus’s service offering; founder Chuck Peipher will join Citrus’s executive leadership as Chief Strategy Officer while remaining CEO of Mirador Global.
-
Sunshine Biopharma Inc. Acquires Nora Pharma Inc.
October 20, 2022
Pharmaceuticals
Sunshine Biopharma Inc. has completed the acquisition of all outstanding shares of Nora Pharma Inc., making Nora Pharma a wholly owned subsidiary. The deal (C$30.0 million) expands Sunshine’s business into generic prescription drugs, over‑the‑counter products and biosimilars and adds approximately $10.7 million in revenue and 36 employees based in the Greater Montreal area.
-
MediPharm Labs Corp. Acquires VIVO Cannabis Inc.
April 1, 2023
Pharmaceuticals
Effective April 1, 2023, MediPharm Labs Corp. completed an all-equity arrangement to acquire all outstanding shares of VIVO Cannabis Inc., making VIVO a wholly-owned subsidiary. Under the arrangement, former VIVO shareholders received 0.2910 MediPharm common shares per VIVO share and MediPharm issued approximately 107,930,964 shares as consideration; VIVO shares are expected to be delisted from the Toronto Stock Exchange.
-
Arcadia Consumer Healthcare (Bansk Group-backed) Acquires Avrio Health Assets
June 5, 2023
Consumer Products
Arcadia Consumer Healthcare, a Bansk Group-backed consumer healthcare platform, has acquired substantially all of the assets of Avrio Health L.P., adding brands including Betadine, Colace, Senokot and SlowMag to its portfolio. The transaction is intended to expand Arcadia's product offerings and leverage its omni-channel distribution and retail relationships to drive growth.
-
Navitus Health Solutions Acquires EpiphanyRx; Lumicera Purchases Quality Drug Clinical Care
July 19, 2021
Healthcare Services
Navitus Health Solutions has acquired EpiphanyRx to broaden its PBM capabilities and mid-market employer reach. Its specialty pharmacy arm, Lumicera Health Services, also acquired Quality Drug Clinical Care in Irvine, California to expand Lumicera's specialty pharmacy footprint and HIV clinical services in the western United States.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.